Modern prostate cancer biomarkers. Prospects for EN2 in the prostate cancer diagnosis

IF 0.1 Q4 ONCOLOGY

Onkourologiya Pub Date : 2020-11-19 DOI:10.17650/1726-9776-2020-16-3-165-173

A. Tarabayeva, A. B. Zhubanturliyeva, I. M. Okhas

引用次数: 0

Abstract

Prostate cancer is one of the most common forms of malignant neoplasms in men. In this regard, it is relevant to search for diagnostic markers that allow the creation of inexpensive, effective tests for early diagnosis of the disease, predicting the risk of relapse and assessing the effectiveness of the therapy. Existing invasive methods for diagnosing prostate cancer present some difficulties for patients. This article discusses the diagnostic capabilities of tissue biomarkers of prostate cancer obtained by non-invasive methods.

查看原文本刊更多论文

现代前列腺癌生物标志物。EN2在前列腺癌诊断中的应用前景

前列腺癌是男性最常见的恶性肿瘤之一。在这方面，有必要寻找诊断标记物，以便为疾病的早期诊断创造廉价、有效的检测方法，预测复发风险并评估治疗的有效性。现有的侵入性前列腺癌诊断方法给患者带来了一些困难。本文讨论了非侵入性前列腺癌组织生物标志物的诊断能力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Onkourologiya ONCOLOGY-

CiteScore

0.40

自引率

0.00%

发文量

审稿时长

10 weeks

期刊介绍： The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.